Publications
- New options of expensive pneumo-oncological therapy for advanced non-small-cell lung carcinoma (NSCLC) in the first line based on morphological and molecular genetic diagnosis in the Czech Republic2012 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
- Treatment of lung cancer2009 | Third Faculty of Medicine
- Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial2003 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, First Faculty of Medicine
- Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial2021 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Central Library of Charles University
- Treatment of malignant pleural mesothelioma in the Czech Republic2019 | Faculty of Medicine in Pilsen, Central Library of Charles University
- First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer2017 | Central Library of Charles University
- Rare tumours in oncology2015 | Third Faculty of Medicine, First Faculty of Medicine, Second Faculty of Medicine
- 5 Vzácné nitrohrudní nádory2015 | Third Faculty of Medicine
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial2014 | Third Faculty of Medicine
- Erlotinib in the treatment of advanced squamous cell NSCLC2013 | Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...